Palliative care in patients with primary brain tumors

被引:45
作者
Taillibert, S [1 ]
Laigle-Donadey, F [1 ]
Sanson, M [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, Serv Neurol, Div Mazarin, F-75013 Paris, France
关键词
best supportive care; palliative care; brain tumors; gliomas;
D O I
10.1097/01.cco.0000142075.75591.02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Because patients with primary brain tumors often present severe functional impairment as well as behavioral/cognitive dysfunction, they suffer from greater dependency and hopelessness than other cancer patients. Optimal management should not only focus on symptom relief through medication and physiotherapy, but should also take into account the psychosocial burden of the disease on the patients and their caregivers. This review updates available data on supportive care in patients with brain tumor. Recent findings Recent improvements have been made in the management of several complications of brain tumor: pain, epilepsy, and side effects of antiepileptic drugs; disability and related thromboembolic complications; cognitive disorders of mixed (tumoral and/or iatrogenic) origin; side effects of steroids; fatigue; and psychological consequences of the disease. Summary Avoiding useless "overtreatment" is the governing idea. A very thorough evaluation of the benefit/risk ratios is needed each time a new treatment is being considered. Brain tumor patients are particularly prone to develop severe side effects, increased fatigue, and cognitive deterioration following apparently minor changes in symptomatic treatments. Care is also needed to avoid useless prolongation of a burdensome situation. Another issue is that patients and their caregivers should benefit from the support of a multidisciplinary team to maintain realistic hopes and to anticipate critical decisions. Finally, guidelines from the literature are proposed to improve physicians' communication skills when treating these patients.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 42 条
  • [1] Baile Walter F, 2003, J Clin Oncol, V21, p49s, DOI 10.1200/JCO.2003.01.169
  • [2] Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations
    Bennett, CL
    Somerfield, MR
    Pfister, DG
    Tomori, C
    Yakren, S
    Bach, PB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 937 - 941
  • [3] Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer
    Breitbart, W
    Rosenfeld, B
    Pessin, H
    Kaim, M
    Funesti-Esch, J
    Galietta, M
    Nelson, CJ
    Brescia, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (22): : 2907 - 2911
  • [4] BRUERA E, 2003, P AN M AM SOC CLIN, V22, P737
  • [5] CERNY T, 2003, P AN M AM SOC CLIN, V22, P730
  • [6] CHANG CY, 2003, P AN M AM SOC CLIN, V22, P775
  • [7] Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms
    Cleeland, CS
    Bennett, GJ
    Dantzer, R
    Dougherty, PM
    Dunn, AJ
    Meyers, CA
    Miller, AH
    Payne, R
    Reuben, JM
    Wang, XS
    Lee, BN
    [J]. CANCER, 2003, 97 (11) : 2919 - 2925
  • [8] COLLINS A, 2003, P AN M AM SOC CLIN, V22, P733
  • [9] Decker Sheila A, 2003, Pain Manag Nurs, V4, P77, DOI 10.1016/S1524-9042(02)54209-0
  • [10] METHYLPHENIDATE IN NEUROPSYCHOLOGICAL SEQUELAE OF RADIOTHERAPY AND CHEMOTHERAPY OF CHILDHOOD BRAIN-TUMORS AND LEUKEMIA
    DELONG, R
    FRIEDMAN, H
    FRIEDMAN, N
    GUSTAFSON, K
    OAKES, J
    [J]. JOURNAL OF CHILD NEUROLOGY, 1992, 7 (04) : 462 - 463